BCTX
Price
$2.96
Change
-$0.15 (-4.82%)
Updated
Jun 27 closing price
Capitalization
20.26M
ELDN
Price
$2.69
Change
-$0.05 (-1.82%)
Updated
Jun 27 closing price
Capitalization
161.08M
38 days until earnings call
Interact to see
Advertisement

BCTX vs ELDN

Header iconBCTX vs ELDN Comparison
Open Charts BCTX vs ELDNBanner chart's image
Briacell Therapeutics Corp NEW
Price$2.96
Change-$0.15 (-4.82%)
Volume$94.81K
Capitalization20.26M
Eledon Pharmaceuticals
Price$2.69
Change-$0.05 (-1.82%)
Volume$7.56M
Capitalization161.08M
BCTX vs ELDN Comparison Chart in %
Loading...
BCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCTX vs. ELDN commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCTX is a Hold and ELDN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (BCTX: $2.96 vs. ELDN: $2.69)
Brand notoriety: BCTX and ELDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCTX: 6% vs. ELDN: 2080%
Market capitalization -- BCTX: $20.26M vs. ELDN: $161.08M
BCTX [@Biotechnology] is valued at $20.26M. ELDN’s [@Biotechnology] market capitalization is $161.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCTX’s FA Score shows that 1 FA rating(s) are green whileELDN’s FA Score has 0 green FA rating(s).

  • BCTX’s FA Score: 1 green, 4 red.
  • ELDN’s FA Score: 0 green, 5 red.
According to our system of comparison, ELDN is a better buy in the long-term than BCTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCTX’s TA Score shows that 4 TA indicator(s) are bullish while ELDN’s TA Score has 3 bullish TA indicator(s).

  • BCTX’s TA Score: 4 bullish, 3 bearish.
  • ELDN’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BCTX is a better buy in the short-term than ELDN.

Price Growth

BCTX (@Biotechnology) experienced а -3.27% price change this week, while ELDN (@Biotechnology) price change was -1.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.65%. For the same industry, the average monthly price growth was +32.92%, and the average quarterly price growth was +6.78%.

Reported Earning Dates

ELDN is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELDN($161M) has a higher market cap than BCTX($20.3M). ELDN YTD gains are higher at: -34.709 vs. BCTX (-65.074). BCTX has higher annual earnings (EBITDA): -27.19M vs. ELDN (-77.67M). ELDN has more cash in the bank: 125M vs. BCTX (5.01M). BCTX has less debt than ELDN: BCTX (27K) vs ELDN (880K). BCTX (0) and ELDN (0) have equivalent revenues.
BCTXELDNBCTX / ELDN
Capitalization20.3M161M13%
EBITDA-27.19M-77.67M35%
Gain YTD-65.074-34.709187%
P/E RatioN/A4.81-
Revenue00-
Total Cash5.01M125M4%
Total Debt27K880K3%
FUNDAMENTALS RATINGS
BCTX vs ELDN: Fundamental Ratings
BCTX
ELDN
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
36
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
9265
P/E GROWTH RATING
1..100
182
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ELDN's Valuation (36) in the Pharmaceuticals Major industry is somewhat better than the same rating for BCTX (96) in the null industry. This means that ELDN’s stock grew somewhat faster than BCTX’s over the last 12 months.

ELDN's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as BCTX (100) in the null industry. This means that ELDN’s stock grew similarly to BCTX’s over the last 12 months.

ELDN's SMR Rating (94) in the Pharmaceuticals Major industry is in the same range as BCTX (100) in the null industry. This means that ELDN’s stock grew similarly to BCTX’s over the last 12 months.

ELDN's Price Growth Rating (65) in the Pharmaceuticals Major industry is in the same range as BCTX (92) in the null industry. This means that ELDN’s stock grew similarly to BCTX’s over the last 12 months.

BCTX's P/E Growth Rating (1) in the null industry is significantly better than the same rating for ELDN (82) in the Pharmaceuticals Major industry. This means that BCTX’s stock grew significantly faster than ELDN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCTXELDN
RSI
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
89%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 19 days ago
80%
N/A
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
BCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACGYF15.93N/A
N/A
Subsea 7 S.A.
CESDF4.82-0.06
-1.23%
CES Energy Solutions Corp.
NISTF19.16-0.57
-2.87%
Nippon Steel Corporation
GCEI0.08N/A
-2.96%
Global Clean Energy, Inc.
BCBNF0.61-0.02
-3.78%
Base Carbon Inc.

BCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCTX has been loosely correlated with KROS. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if BCTX jumps, then KROS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCTX
1D Price
Change %
BCTX100%
-4.82%
KROS - BCTX
33%
Loosely correlated
-0.15%
ELDN - BCTX
29%
Poorly correlated
-1.82%
IPSC - BCTX
28%
Poorly correlated
-5.74%
SRZN - BCTX
26%
Poorly correlated
+8.02%
LGVN - BCTX
26%
Poorly correlated
+1.54%
More

ELDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELDN has been loosely correlated with CDXS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ELDN jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELDN
1D Price
Change %
ELDN100%
-1.82%
CDXS - ELDN
38%
Loosely correlated
-5.16%
ABSI - ELDN
37%
Loosely correlated
-3.32%
MREO - ELDN
37%
Loosely correlated
-5.00%
AMLX - ELDN
36%
Loosely correlated
N/A
DNLI - ELDN
36%
Loosely correlated
-2.69%
More